You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (130)

Journals (0)

1-10 of 130 results for programmed cell death-ligand 1(PD-L1) inhibitor

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Clinical Experience of External Application of Clearing Heat and Removing Dampness in Relieving Grade 2 to 3 Rash Caused by Programed Cell Death Protein 1 (PD-1)/Programed Cell Death Ligand 1 (PD-L1) Inhibitors: A Single-Center Retrospective Study

Open access

Research article

First published 2024

Clinical Experience of External Application of Clearing Heat and Removing Dampness in Relieving Grade 2 to 3 Rash Caused by Programed Cell Death Protein 1 (PD-1)/Programed Cell Death Ligand 1 (PD-L1) Inhibitors: A Single-Center Retrospective Study

Shu-yi Chen, Fang-min Zhao, Rui Yu [...]

Integrative Cancer Therapies

Select article: PD-1 Blockade With Concurrent Radiotherapy for Locally Advanced Inoperable Cutaneous Squamous Cell Carcinoma

Retricted access

Research article

First published 2022-5

PD-1 Blockade With Concurrent Radiotherapy for Locally Advanced Inoperable Cutaneous Squamous Cell Carcinoma

Kurian Joseph, John Walker, Hamid Raziee [...]

Journal of Cutaneous Medicine and Surgery

Select article: Novel Therapies in Platinum-refractory Metastatic Germ Cell Tumor: A Case Report with a Focus on a PD-1 Inhibitor

Open access

Case report

First published 2017-7

Novel Therapies in Platinum-refractory Metastatic Germ Cell Tumor: A Case Report with a Focus on a PD-1 Inhibitor

Kah Poh Loh, Chunkit Fung

Rare Tumors

Select article: Role of immune-checkpoint inhibitors in lung cancer

Open access

Review article

First published 2018

Role of immune-checkpoint inhibitors in lung cancer

Prantesh Jain, Chhavi Jain, Vamsidhar Velcheti

Therapeutic Advances in Respiratory Disease

Select article: PD-L1 expression testing in non-small cell lung cancer

Open access

Review article

First published 2018

PD-L1 expression testing in non-small cell lung cancer

Cristina Teixidó, Noelia Vilariño, Roxana Reyes [...]

Therapeutic Advances in Medical Oncology

Select article: Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non–Small Cell Lung Cancer

Open access

Review article

First published 2019

Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non–Small Cell Lung Cancer

Jia-Xin Li, Ju-Min Huang, Ze-Bo Jiang [...]

Integrative Cancer Therapies

Select article: Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Retricted access

Review article

First published 2021-8

Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Yiyi Cao, Wenbo Li, ZhengJie Wang [...]

Tumori Journal

Select article: Immune checkpoint inhibitors in ovarian cancer: where do we stand?

Open access

Review article

First published 2021

Immune checkpoint inhibitors in ovarian cancer: where do we stand?

Alexandra Leary, David Tan, Jonathan Ledermann

Therapeutic Advances in Medical Oncology

Select article: The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer

Open access

Review article

First published 2021

The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer

Jingjing Qu, Quanhui Mei, Li Liu [...]

Therapeutic Advances in Medical Oncology

Select article: Survival Outcomes and Safety of Programmed Cell Death/Programmed Cell Death Ligand 1 Inhibitors for Unresectable Hepatocellular Carcinoma: Result From Phase III Trials

Open access

Research article

First published 2022-4

Survival Outcomes and Safety of Programmed Cell Death/Programmed Cell Death Ligand 1 Inhibitors for Unresectable Hepatocellular Carcinoma: Result From Phase III Trials

Linyan Zeng, Junwei Su, Wenqi Qiu [...]

Cancer Control

1
2
3
•••
13
10 / page

Article type

Publication date

Subjects

Access